[go: up one dir, main page]

NL7613451A - 3,4-digesubstitueerde 2-((beta)-naftoxy)-ethylpyra- zolonen. - Google Patents

3,4-digesubstitueerde 2-((beta)-naftoxy)-ethylpyra- zolonen.

Info

Publication number
NL7613451A
NL7613451A NL7613451A NL7613451A NL7613451A NL 7613451 A NL7613451 A NL 7613451A NL 7613451 A NL7613451 A NL 7613451A NL 7613451 A NL7613451 A NL 7613451A NL 7613451 A NL7613451 A NL 7613451A
Authority
NL
Netherlands
Prior art keywords
zolons
naftoxy
ethylpyra
dig
beta
Prior art date
Application number
NL7613451A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NL7613451A publication Critical patent/NL7613451A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7613451A 1975-12-05 1976-12-02 3,4-digesubstitueerde 2-((beta)-naftoxy)-ethylpyra- zolonen. NL7613451A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752554701 DE2554701A1 (de) 1975-12-05 1975-12-05 3,4-disubstituierte 2-(beta-naphthyloxy)-aethylpyrazolone

Publications (1)

Publication Number Publication Date
NL7613451A true NL7613451A (nl) 1977-06-07

Family

ID=5963526

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7613451A NL7613451A (nl) 1975-12-05 1976-12-02 3,4-digesubstitueerde 2-((beta)-naftoxy)-ethylpyra- zolonen.

Country Status (9)

Country Link
JP (1) JPS5271467A (es)
BE (1) BE849047A (es)
DE (1) DE2554701A1 (es)
DK (1) DK545676A (es)
ES (1) ES453908A1 (es)
FR (1) FR2333505A1 (es)
LU (1) LU76328A1 (es)
NL (1) NL7613451A (es)
SE (1) SE7613536L (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432062A1 (de) * 1984-08-31 1986-03-06 Bayer Ag, 5090 Leverkusen Pyrazoldionderivate und ihre anwendung bei der bekaempfung von krankheiten
JP3994453B2 (ja) * 1995-10-13 2007-10-17 日産化学工業株式会社 ピラゾロン類
CN104945294B (zh) * 2014-03-31 2016-09-07 中国科学院上海有机化学研究所 含三氟甲硫基的化合物及其制备方法
CN104974065A (zh) * 2015-06-15 2015-10-14 华东理工大学 一种制备α-三氟甲硫基化酮类化合物的方法

Also Published As

Publication number Publication date
ES453908A1 (es) 1977-11-16
FR2333505A1 (fr) 1977-07-01
BE849047A (fr) 1977-06-03
JPS5271467A (en) 1977-06-14
DE2554701A1 (de) 1977-06-08
LU76328A1 (es) 1977-11-21
DK545676A (da) 1977-06-06
SE7613536L (sv) 1977-06-06

Similar Documents

Publication Publication Date Title
SE7600224L (sv) Lopare for blixtlas.
SE7604095L (sv) 4,4-dihydrospiro-2h-1,3-bensoxaziner
BE847073A (fr) 1,4-bis-(azolyl-(2'))-naphtalenes,
FR2334674A1 (fr) 1,4-diphenyl-3-pyrazolin-5-ones herbicides
NL7920160A (nl) 24,24-difluor-25-hydroxycholecalciferol.
NL7803720A (nl) (1,5)pyrido2,3-bbenzothiazepine-derivaten.
SE7609769L (sv) 1,2-bensisoxazolderivat
NL7607985A (nl) 12-alkoxy-3,7,11-trimethyldodecatetraenen.
BE837664A (fr) (2,3-dihydroergolines
NL7610150A (nl) 1,5-dihydro-2h-1,4-benzodiazepin-2-on derivaten.
BE849092A (fr) 1,4-diphenyl-3-pyrazolin-5-one herbicides
SE7608452L (sv) 2,4-diamino-5-benzylpyrimidiner
NL7613451A (nl) 3,4-digesubstitueerde 2-((beta)-naftoxy)-ethylpyra- zolonen.
SE7608417L (sv) 2-klor-n-isopropyl-2',3'-dimetylacetanilid
DK534976A (da) Substituerede 2,1,3-benzothiadiazin-forbindelser
IT1196913B (it) 6,7 secoergoline
NL7613511A (nl) Gesubstitueerde 2-((beta)-naftoxy)-ethylpyrazolonen.
NL7803610A (nl) 2,4,6-trigesubstitueerde 2,3-dihydrobenzofuranen.
BE838466A (fr) 1,3-dialcoyl-7-oxoalcoylxanthines
NL7603141A (nl) Transfermateriaal.
NL7605486A (nl) "round-up" caroussel.
NL7504783A (nl) Stralingsgevoelig materiaal.
ES211713Y (es) Nueva caja-envase.
NL7808193A (nl) Biocide-actieve 1,2,3-benzotrisulfiden.
BE838467A (fr) 1,3-dialcoyl-7-oxoalcoylxanthines

Legal Events

Date Code Title Description
BV The patent application has lapsed